Kanghong Pharmaceuticals has established a biotechnology company in Beijing.

According to the QiChaCha app, Beijing Hongsheng Ruihe Biotechnology Co., Ltd. was recently established, with Ke Xiao as the legal representative and a registered capital of 38 million yuan. The scope of business includes: research and development of biological chemical products; medical research and experimental development; research and application of cell technology; research and development of biobased materials technology. Equity penetration information from QiChaCha shows that the company is wholly owned by Sichuan Honghe Biotechnology Co., Ltd., a subsidiary of Kanghong Pharmaceutical.